Literature DB >> 7780640

Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.

S L Cox1, A Ben, D F Story, J Ziogas.   

Abstract

1. The effects of the nonpeptide angiotensin II receptor (AT) antagonists losartan and PD 123319 on actions of angiotensin II in the rat caudal artery and rat vas deferens preparations were investigated. 2. Angiotensin II (1.0 microM) increased perfusion pressure in isolated segments of the rat caudal artery. This increase in perfusion pressure was prevented by the AT1-antagonist, losartan (0.1 microM) but was not affected by the AT2-antagonist, PD 123319 (0.1 microM). 3. Angiotensin II (0.1-3.0 microM) produced a concentration-dependent enhancement of the stimulation-induced (S-I) efflux of [3H]-noradrenaline from isolated segments of rat caudal artery in which the noradrenergic transmitter stores had been labelled with [3H]-noradrenaline. The maximum enhancement of S-I efflux was approximately 60% with 1.0 microM angiotensin II. 4. Losartan (0.01 and 0.1 microM) reduced the enhancement of S-I efflux produced by 1.0 microM angiotensin II in the caudal artery. 5. PD 123319 (0.01 microM) did not affect the enhancement of S-I efflux produced by angiotensin II (1.0 microM) in the caudal artery. However, in a higher concentration (0.1 microM), PD 123319 reduced the enhancement of S-I efflux produced by 1.0 microM angiotensin II. 6. Angiotensin II produced concentration-dependent enhancement of the purinergic twitch responses (1 pulse/60 s) in the rat vas deferens. 7. Losartan (0.03 microM) and PD 123319 (0.03 microM) each reduced the angiotensin II-induced enhancement of the twitch responses in the rat vas deferens. 8. These findings indicate that the enhancement of sympathetic neuroeffector transmission in both the caudal artery and vas deferens of the rat involves angiotensin receptor subtype(s) sensitive to both losartan and PD 123319. In contrast, the direct vasoconstrictor effect of angiotensin II in the rat caudal artery involves activation of a receptor subtype sensitive only to losartan.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780640      PMCID: PMC1510322          DOI: 10.1111/j.1476-5381.1995.tb13313.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

Review 1.  Pharmacology of nonpeptide angiotensin II receptor antagonists.

Authors:  R D Smith; A T Chiu; P C Wong; W F Herblin; P B Timmermans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1992       Impact factor: 13.820

2.  Identification of angiotensin II receptor subtypes.

Authors:  A T Chiu; W F Herblin; D E McCall; R J Ardecky; D J Carini; J V Duncia; L J Pease; P C Wong; R R Wexler; A L Johnson
Journal:  Biochem Biophys Res Commun       Date:  1989-11-30       Impact factor: 3.575

3.  Angiotensin effects on vas deferens adrenergic and purinergic neurotransmission.

Authors:  G J Trachte
Journal:  Eur J Pharmacol       Date:  1988-02-09       Impact factor: 4.432

4.  Effects of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria.

Authors:  J Ziogas; D F Story; M J Rand
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

5.  Attenuation by prostaglandins of the facilitatory effect of angiotensin II at adrenergic prejunctional sites in the isolated Krebs-perfused rat heart.

Authors:  S M Lanier; K U Malik
Journal:  Circ Res       Date:  1982-11       Impact factor: 17.367

6.  Prostaglandins do not mediate the inhibitory effects of angiotensins II and III on autonomic neurotransmission in the rabbit vas deferens.

Authors:  G J Trachte
Journal:  Prostaglandins       Date:  1988-08

7.  Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

8.  Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.

Authors:  P C Wong; W A Price; A T Chiu; D J Carini; J V Duncia; A L Johnson; R R Wexler; P B Timmermans
Journal:  Hypertension       Date:  1990-06       Impact factor: 10.190

9.  Preliminary biochemical characterization of two angiotensin II receptor subtypes.

Authors:  S Whitebread; M Mele; B Kamber; M de Gasparo
Journal:  Biochem Biophys Res Commun       Date:  1989-08-30       Impact factor: 3.575

10.  Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors.

Authors:  J Kunert-Radek; H Stepień; J Komorowski; M Pawlikowski
Journal:  Biochem Biophys Res Commun       Date:  1994-02-15       Impact factor: 3.575

View more
  9 in total

1.  Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues.

Authors:  S L Cox; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  The role of the kidney and the sympathetic nervous system in hypertension.

Authors:  Philip Thomas; Indranil Dasgupta
Journal:  Pediatr Nephrol       Date:  2014-03-08       Impact factor: 3.714

3.  Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 5.  Differentiation in the angiotensin II receptor 1 blocker class on autonomic function.

Authors:  H Krum
Journal:  Curr Hypertens Rep       Date:  2001-09       Impact factor: 5.369

6.  A pharmacological differentiation between postjunctional (AT1A) and prejunctional (AT1B) angiotensin II receptors in the rabbit aorta.

Authors:  Serafim Guimarães; Catarina Carneiro; Fernando Brandão; Helder Pinheiro; António Albino-Teixeira; Daniel Moura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-23       Impact factor: 3.000

7.  Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.

Authors:  Mirnela Byku; Heather Macarthur; Thomas C Westfall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

8.  Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?

Authors:  Xiang Wang; Ana-Maria Bosonea; Jeffrey Odenbach; Carlos Fernandez-Patron
Journal:  Curr Hypertens Rev       Date:  2012-08-01

9.  Spinal cord injury increases the reactivity of rat tail artery to angiotensin II.

Authors:  Hussain Al Dera; James A Brock
Journal:  Front Neurosci       Date:  2015-01-06       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.